Cramer Kristie, Wiebe Natasha, Moyer Virginia, Hartling Lisa, Williams Katrina, Swingler George, Klassen Terry P
Alberta Research Centre for Child Health Evidence, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
BMC Pediatr. 2005 Sep 21;5:38. doi: 10.1186/1471-2431-5-38.
The delivery of optimal medical care to children is dependent on the availability of child relevant research. Our objectives were to: i) systematically review and describe how children are handled in reviews of drug interventions published in the Cochrane Database of Systematic Reviews (CDSR); and ii) determine when effect sizes for the same drug interventions differ between children and adults.
We systematically identified all of the reviews relevant to child health in the CDSR 2002, Issue 4. Reviews were included if they investigated the efficacy or effectiveness of a drug intervention for a condition that occurs in both children and adults. Information was extracted on review characteristics including study methods, results, and conclusions.
From 1496 systematic reviews, 408 (27%) were identified as relevant to both adult and child health; 52% (213) of these included data from children. No significant differences were found in effect sizes between adults and children for any of the drug interventions or conditions investigated. However, all of the comparisons lacked the power to detect a clinically significant difference and wide confidence intervals suggest important differences cannot be excluded. A large amount of data was unavailable due to inadequate reporting at the trial and systematic review level.
Overall, the findings of this study indicate there is a paucity of child-relevant and specific evidence generated from evidence syntheses of drug interventions. The results indicate a need for a higher standard of reporting for participant populations in studies of drug interventions.
为儿童提供优质医疗服务取决于是否有与儿童相关的研究。我们的目标是:i)系统回顾并描述在《考克兰系统评价数据库》(CDSR)中发表的药物干预评价中儿童是如何被处理的;ii)确定相同药物干预在儿童和成人中的效应大小何时存在差异。
我们系统检索了CDSR 2002年第4期所有与儿童健康相关的评价。如果评价调查了一种在儿童和成人中均会出现的疾病的药物干预的疗效或有效性,则纳入该评价。提取了包括研究方法、结果和结论在内的评价特征信息。
在1496篇系统评价中,408篇(27%)被确定与成人和儿童健康均相关;其中52%(213篇)纳入了儿童数据。在所调查的任何药物干预或疾病中,未发现成人和儿童在效应大小上存在显著差异。然而,所有比较均缺乏检测临床显著差异的效力,且宽置信区间表明不能排除存在重要差异。由于试验和系统评价层面报告不充分,大量数据无法获取。
总体而言,本研究结果表明,药物干预证据综合产生的与儿童相关的具体证据匮乏。结果表明,在药物干预研究中,需要提高对研究对象人群的报告标准。